Skip to content

[ivory-search id="184" title="Recordati AJAX Search Form"]

Our Offices
Careers
Contact Us
Italiano
English

Company
- Company Block 1
  - Who we are
  - Our Story
- Company Block 2
  - Leadership
  - Partnering
Governance
Business
- business block 1
- business block 2
Investors
Sustainability
People
- Careers Block 1
Media

RECORDATI: ISTURISA® (OSILODROSTAT) APPROVED IN JAPAN, – 2021-03-24 11:00:00 – Business & Financial News

Published 24 March 2021By steve@tiuhealth.com

Categorised as Business & Financial News

Post navigation

Previous post

Press release (on “il Sole 24 Ore”) – Extract of the call notice of the Ordinary Shareholders meeting 20.04.2021, – 2021-03-20 11:00:00 – Announcements

Next post

RECORDATI: PUBLIC DISCLOSURE (DOCUMENTS RELATING TO THE ORDINARY GENERAL MEETING OF THE SHAREHOLDERS’ 20.04.2021) – 2021-03-25 11:00:00 – Announcements

Alert Services
Safety Reporting
Privacy Policy
Privacy Policy: HCP
Cookie Policy
Legal Notice

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.
VIA MATTEO CIVITALI, 1 – 20148 MILAN, ITALY
SHARE CAPITAL € 26.140.644,50 I.V.
REG. IMP. MILANO, MONZA, BRIANZA E LODI 00748210150
FISCAL CODE/VAT NO. IT00748210150
Company subject to the Management and Coordination Activities of Rossini Luxembourg S.àr.l.

Copyright © 2025 – Recordati Industria Chimica e Farmaceutica S.p.A all rights reserved